Chen S, Wang C, Huang T, Tsai J, Wang H, Yen Y
Cells. 2024; 13(18.
PMID: 39329778
PMC: 11430802.
DOI: 10.3390/cells13181597.
Umar H, Aliyu M, Usman A, Ghali U, Isah Abba S, Ozsahin D
Sci Rep. 2023; 13(1):22242.
PMID: 38097683
PMC: 10721884.
DOI: 10.1038/s41598-023-49363-z.
Moshe D, Baghaie L, Leroy F, Skapinker E, Szewczuk M
Biomedicines. 2023; 11(8).
PMID: 37626639
PMC: 10452636.
DOI: 10.3390/biomedicines11082142.
Pan S, Wang N, Song X
Zhongguo Fei Ai Za Zhi. 2022; 25(8):615-621.
PMID: 36002199
PMC: 9411950.
DOI: 10.3779/j.issn.1009-3419.2022.102.23.
Cheng S, Wu A, El-Saber Batiha G, Ho C, Lee J, Lukman H
Biology (Basel). 2022; 11(2).
PMID: 35205190
PMC: 8869712.
DOI: 10.3390/biology11020324.
Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells.
Rabelo-Fernandez R, Santiago-Sanchez G, Sharma R, Roche-Lima A, Carrion K, Noriega Rivera R
Int J Mol Sci. 2022; 23(1).
PMID: 35008958
PMC: 8745614.
DOI: 10.3390/ijms23010535.
Ovulation sources coagulation protease cascade and hepatocyte growth factor to support physiological growth and malignant transformation.
Huang H, Chen P, Chu S, Lee M, Huang C, Chu T
Neoplasia. 2021; 23(11):1123-1136.
PMID: 34688971
PMC: 8550993.
DOI: 10.1016/j.neo.2021.09.006.
Knockout of Hepatocyte Growth Factor by CRISPR/Cas9 System Induces Apoptosis in Hepatocellular Carcinoma Cells.
Lee H, Lim H, Park S, Nam M
J Pers Med. 2021; 11(10).
PMID: 34683124
PMC: 8540514.
DOI: 10.3390/jpm11100983.
Targeted Therapy Approaches for MET Abnormalities in Non-Small Cell Lung Cancer.
Garon E, Brodrick P
Drugs. 2021; 81(5):547-554.
PMID: 33638808
DOI: 10.1007/s40265-021-01477-2.
Novel insights into the interaction between long non-coding RNAs and microRNAs in glioma.
Ebrahimpour A, Sarfi M, Rezatabar S, Tehrani S
Mol Cell Biochem. 2021; 476(6):2317-2335.
PMID: 33582947
DOI: 10.1007/s11010-021-04080-x.
Human colorectal cancer-derived carcinoma associated fibroblasts promote CD44-mediated adhesion of colorectal cancer cells to endothelial cells by secretion of HGF.
Zhang R, Qi F, Shao S, Li G, Feng Y
Cancer Cell Int. 2019; 19:192.
PMID: 31367190
PMC: 6657169.
DOI: 10.1186/s12935-019-0914-y.
Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells.
Vengoji R, Ponnusamy M, Rachagani S, Mahapatra S, Batra S, Shonka N
Carcinogenesis. 2018; 40(1):2-14.
PMID: 30475990
PMC: 6412134.
DOI: 10.1093/carcin/bgy171.
Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC).
Monk P, Liu G, Stadler W, Geyer S, Huang Y, Wright J
Invest New Drugs. 2018; 36(5):919-926.
PMID: 30083962
PMC: 6153554.
DOI: 10.1007/s10637-018-0630-9.
Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.
Zhao Y, Liu P, Zhang N, Chen J, Landegger L, Wu L
Proc Natl Acad Sci U S A. 2018; 115(9):E2077-E2084.
PMID: 29440379
PMC: 5834719.
DOI: 10.1073/pnas.1719966115.
The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches.
Hu C, Wu J, Cheng C, Wu W
Cancers (Basel). 2017; 9(6).
PMID: 28587113
PMC: 5483877.
DOI: 10.3390/cancers9060058.
HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation.
Spina A, De Pasquale V, Cerulo G, Cocchiaro P, Della Morte R, Avallone L
Biomedicines. 2017; 3(1):71-88.
PMID: 28536400
PMC: 5344235.
DOI: 10.3390/biomedicines3010071.
Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment.
Owusu B, Galemmo R, Janetka J, Klampfer L
Cancers (Basel). 2017; 9(4).
PMID: 28420162
PMC: 5406710.
DOI: 10.3390/cancers9040035.
Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies.
Takahashi N, Iwasa S, Taniguchi H, Sasaki Y, Shoji H, Honma Y
Br J Cancer. 2016; 114(9):1003-11.
PMID: 27002940
PMC: 4984915.
DOI: 10.1038/bjc.2016.74.
Stable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK Cells.
Chu C, Bottaro D, Betenbaugh M, Shiloach J
PLoS One. 2016; 11(2):e0148075.
PMID: 26848584
PMC: 4743853.
DOI: 10.1371/journal.pone.0148075.
Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma.
Brauswetter D, Danos K, Gurbi B, Felegyhazi E, Birtalan E, Meggyeshazi N
Virchows Arch. 2016; 468(5):579-87.
PMID: 26832731
DOI: 10.1007/s00428-016-1905-1.